CICS-UBI - Health Sciences Research Centre, Universidade da Beira Interior, Av. Infante D. Henrique, 6200-506, Covilhã, Portugal.
CICS-UBI - Health Sciences Research Centre, Universidade da Beira Interior, Av. Infante D. Henrique, 6200-506, Covilhã, Portugal; CIEPQF - Departamento de Engenharia Química, Universidade de Coimbra, Rua13 Sílvio Lima, 3030-790, Coimbra, Portugal.
Pharmacol Res. 2019 Oct;148:104438. doi: 10.1016/j.phrs.2019.104438. Epub 2019 Aug 30.
Macroscale delivery systems that can be locally implanted on the tumor tissue as well as avoid all the complications associated to the systemic delivery of therapeutics have captured researchers' attention, in recent years. Particularly, the microneedle-based devices can be used to efficiently deliver both small and macro-molecules, like chemotherapeutics, proteins, and genetic material, along with nanoparticle-based anticancer therapies. Such capacity prompted the application of microneedle devices for the development of new anticancer vaccines that can permeate the tumor tissue and simultaneously improve the effectiveness of therapeutic agents. Based on the promising results demonstrated by the microneedle systems in the local administration of anticancer therapeutics, this review summarizes the different microneedle formulations developed up to now aimed for application on cancer therapy (mphasizing those produced with polymers). Additionally, the microneedles' general properties, type of therapeutic approach and its main advantages are also highlighted.
近年来,能够局部植入肿瘤组织且避免与全身药物递送相关的所有并发症的宏观递药系统引起了研究人员的关注。特别是,基于微针的装置可用于高效递送小分子和大分子,如化疗药物、蛋白质和遗传物质,以及基于纳米颗粒的抗癌疗法。这种能力促使微针装置应用于开发新的抗癌疫苗,这些疫苗可以渗透肿瘤组织并同时提高治疗剂的效果。基于微针系统在局部递药抗癌治疗中展示出的有前景的结果,本综述总结了迄今为止为应用于癌症治疗而开发的不同微针制剂(重点介绍那些使用聚合物制备的制剂)。此外,还突出了微针的一般特性、治疗方法类型及其主要优点。